Qualigen Therapeutics, Inc. (QLGN) Investment Research Dashboard
About Qualigen Therapeutics, Inc. (QLGN) stock analysis
Get live QLGN stock price $3.21, comprehensive Qualigen Therapeutics, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time QLGN stock data and investment insights.
Loading chart data...
Qualigen Therapeutics, Inc. (QLGN) Overview
Qualigen Therapeutics, Inc. (QLGN) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, QLGN trades at $3.21 with a market capitalization of 5.43M . Over the past 52 weeks, QLGN has traded between $1.61 and $8.81 , with the current price positioned at approximately 22% of this range . The stock currently trade...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 5.43M
- Current price: $3.21
- 52-week range: $1.61 - $8.81
- P/E ratio: 1.13
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Qualigen Therapeutics, Inc. is a biotechnology enterprise focused on advancing groundbreaking treatments for both cancer and infectious diseases. In addition to its developmental pipeline, the company offers FastPack, an efficient system designed for...
Company Information
- CEO
- Kevin A. Richardson II
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 4
Contact Information
- Website
- https://qlgntx.com
- Address
- 2042 Corte Del Nogal
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 1.1)
✓ Lower volatility stock (Beta: 0.28) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Qualigen Therapeutics, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Qualigen Therapeutics, Inc.
- ⚠Investors should consider how Qualigen Therapeutics, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
5.43M
P/E Ratio (TTM)
1.13
Beta
0.28
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare QLGN with peer companies:
- Price
- $3.20+0.31% (1D)
- Market cap
- 4.19M
- Price
- $1.76+2.92% (1D)
- Market cap
- 2.61M
- Price
- $5.40+0.75% (1D)
- Market cap
- 3.10M
- Price
- $0.36-5.78% (1D)
- Market cap
- 3.36M
- Price
- $0.70-5.65% (1D)
- Market cap
- 13.56M
- Price
- $12.00-2.52% (1D)
- Market cap
- 19.44M
- Price
- $0.54-1.82% (1D)
- Market cap
- 2.44M
- Price
- $0.38+1.56% (1D)
- Market cap
- 5.68M
- Price
- $2.34+0.00% (1D)
- Market cap
- 3.11M
- Price
- $2.96+5.34% (1D)
- Market cap
- 5.59M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
72/100 ⭐⭐⭐⭐⭐
- Overall
- +0.4%
- NYSE
- +0.3%
- NASDAQ
- +0.5%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | -0.3% | +1.5% | +4.5% | 19.6 | 93/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.4% | +0.2% | +0.9% | 23.0 | 72/100⭐⭐⭐⭐⭐ |
| Basic Materials | +0.3% | +2.1% | -0.5% | 25.6 | 70/100⭐⭐⭐⭐⭐ |
| Communication Services | -2.4% | -1.2% | +2.1% | 21.3 | 67/100⭐⭐⭐⭐ |
| Real Estate | -0.0% | +0.7% | -2.2% | 27.9 | 53/100⭐⭐⭐ |
| Consumer Defensive | -0.8% | -1.7% | -0.4% | 29.3 | 48/100⭐⭐⭐ |
| Consumer Cyclical | -0.5% | +1.0% | -2.3% | 44.5 | 43/100⭐⭐⭐ |
| Energy | -2.7% | -3.4% | -5.3% | 18.3 | 32/100⭐⭐ |
| Industrials | -0.9% | +1.4% | -6.7% | 33.2 | 30/100⭐⭐ |
| Technology | -0.9% | +0.1% | -5.1% | 44.5 | 27/100⭐⭐ |
| Utilities | -1.1% | -3.7% | -8.7% | 24.2 | 14/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-06.